Knowledge Graph · Medication
Liraglutide
A GLP-1 receptor agonist for type 2 diabetes and weight management.
Authoritative sources
Evidence base
Systematic Review · 2025
Metabolism: clinical and experimental · Karakasis P, Patoulias D, Fragakis N, Mantzoros CS
Meta-Analysis · 2025
Obesity reviews : an official journal of the International Association for the Study of Obesity · Berg S, Stickle H, Rose SJ, Nemec EC
Randomized Controlled Trial · 2025
Liraglutide for Children 6 to <12 Years of Age with Obesity - A Randomized Trial
The New England journal of medicine · Fox CK, Barrientos-Pérez M, Bomberg EM, Dcruz J, et al.
Systematic Review · 2025
Annals of internal medicine · Moiz A, Filion KB, Toutounchi H, Tsoukas MA, et al.
Systematic Review · 2025
Nature medicine · McGowan B, Ciudin A, Baker JL, Busetto L, et al.
Randomized Controlled Trial · 2023
Cardiovascular diabetology · Sandsdal RM, Juhl CR, Jensen SBK, Lundgren JR, et al.
Meta-Analysis · 2023
Semaglutide and cancer: A systematic review and meta-analysis
Diabetes & metabolic syndrome · Nagendra L, Bg H, Sharma M, Dutta D
Randomized Controlled Trial · 2022
JAMA · Rubino DM, Greenway FL, Khalid U, O'Neil PM, et al.
Randomized Controlled Trial · 2021
Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined
The New England journal of medicine · Lundgren JR, Janus C, Jensen SBK, Juhl CR, et al.
Where Liraglutide appears on Kindr Health
Data hub
This page is part of Kindr Health's public Knowledge Graph. Content is for educational purposes only and is not medical advice.